Precigen (PGEN) Short-Term Debt issuances (2014 - 2022)
Precigen (PGEN) posted quarterly Short-Term Debt issuances of -$115.7 million for Q4 2022, down 3704.18% quarter-over-quarter from $3.2 million in Q2 2020.
Analysis
Precigen (PGEN) Short-Term Debt issuances (2014 - 2022) Analysis & Trends
Precigen (PGEN) has reported Short-Term Debt issuances for 8 consecutive years, with -$115.7 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Short-Term Debt issuances changed N/A year-over-year to -$115.7 million; the TTM figure through Dec 2022 stood at -$115.7 million (changed N/A YoY), while the FY2020 annual figure was $11.9 million, up 1.45% from the prior year.
- Short-Term Debt issuances fell to -$115.7 million in Q4 2022 per PGEN's latest filing, from $3.2 million in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $8.7 million in Q1 2020 and bottomed at -$115.7 million in Q4 2022.
- Historically, Short-Term Debt issuances has averaged -$7.9 million across 4 years, with a median of $1.3 million in 2018.
- Annual changes were most pronounced in 2018 — Short-Term Debt issuances slumped 44.88% — and 2020, when it surged 519.18%.
- Precigen's Short-Term Debt issuances stood at $1.3 million in 2018, then soared by 457.98% to $7.2 million in 2019, then sank by 55.66% to $3.2 million in 2020, then tumbled by 3704.18% to -$115.7 million in 2022.
- Business Quant data shows PGEN's Short-Term Debt issuances at -$115.7 million in Q4 2022, $3.2 million in Q2 2020, and $8.7 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -115.66 Mn |
| Jun 30, 2020 | 2.49 Mn |
| Mar 31, 2020 | 9.44 Mn |
| Dec 31, 2019 | 7.13 Mn |
| Sep 30, 2019 | 1.29 Mn |
| Jun 30, 2019 | 1.73 Mn |
| Mar 31, 2019 | 1.60 Mn |
| Dec 31, 2018 | 1.30 Mn |
| Sep 30, 2018 | 986,000.00 |
| Jun 30, 2018 | 1.04 Mn |
| Mar 31, 2018 | 1.24 Mn |
| Dec 31, 2017 | 1.34 Mn |
| Sep 30, 2017 | 1.29 Mn |
| Jun 30, 2017 | 1.77 Mn |
| Mar 31, 2017 | 2.09 Mn |
| Dec 31, 2016 | 2.76 Mn |
| Sep 30, 2016 | 680,000.00 |
| Jun 30, 2016 | 803,000.00 |
| Mar 31, 2016 | 837,000.00 |
| Dec 31, 2015 | 1.43 Mn |